Skip to main content

Table 2 LDL-C (mg/dL) in the 19 patients who completed the study

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

 

Argicolina

Normolip

Argicolina − Normolip

At start of treatment

153.1 ± 11.6

153.1 ± 14.4

0.0 (− 7.3  +7.3)

At end of treatment

113.1 ± 12.8 *

116.7 ± 15.4 *

− 3.7 (−9.5  +2.1)

Δ Final–Initial

−40.1 (−49.2  −30.9)

−36.4 (−45.6  −27.1)

−3.7 (−13.0  +5.6)

% Δ(Final–Initial) / Initial

−25.6 (−31.1 –20.1)

−23.3 (−28.7  −17.9)

−2.3 (−7.4  +2.8)

  1. Data are expressed as mean ± SD, (95%CI), and analyzed by Student’s t test for paired data (end vs. start of treatment), * p < 0.0001